Datopotamab, CAS 2267989-53-5

Product Description: Datopotamab (CDP7657) is an antibody targeting to TROP2. Datopotamab can be used to synthesize Datopotamab deruxtecan (HY-141598), TROP2-directed antibody-drug conjugate (ADC). Datopotamab deruxtecan consists of DNA topoisomerase I inhibitor Deruxtecan (HY-13631E) and Datopotamab[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Okajima D, et al. Datopotamab Deruxtecan, a Novel TROP2-directed Antibody-drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells. Mol Cancer Ther. 2021 Dec;20(12):2329-2340.

CAS Number: 2267989-53-5

Molecular Weight: 145160

Compound Purity: 99.00

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: ADC Antibody;TROP2

• Artikelnummer: MEXHY-P99843-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99843-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated